Cutler Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,994
Closed -$190K 5738
2021
Q4
$190K Buy
+6,994
New +$187K 0.01% 1360
2020
Q3
Sell
-5,300
Closed -$90K 5026
2020
Q2
$90K Buy
+5,300
New +$78.6K 0.01% 1365
2018
Q1
Sell
-998
Closed -$53K 4910
2017
Q4
$53K Sell
998
-2,143
-68% -$101K ﹤0.01% 1814
2017
Q3
$135K Sell
3,141
-2,182
-41% -$104K 0.01% 1437
2017
Q2
$321K Buy
5,323
+4,934
+1,268% +$292K 0.01% 959
2017
Q1
$26K Sell
389
-200
-34% -$13.9K ﹤0.01% 3075
2016
Q4
$39K Buy
589
+300
+104% +$19.5K ﹤0.01% 2795
2016
Q3
$19K Hold
289
﹤0.01% 3470
2016
Q2
$20K Hold
289
﹤0.01% 3366
2016
Q1
$18K Sell
289
-400
-58% -$26.5K ﹤0.01% 3395
2015
Q4
$49K Buy
+689
New +$51K ﹤0.01% 2481

Other funds holding MD

Cutler Group's MD Position: Q1 2022 in Review

Cutler Group sold out of Pediatrix Medical (MD) in Q1 2022, closing a stake of 6,994 shares — an estimated $190K sold.

Cutler Group first reported a position in MD in Q4 2015 and held it in 11 quarters. The position peaked at $321K in Q2 2017. 224 funds tracked by Wall St. Rank hold MD as of Q1 2022.

  • Cutler Group reported no remaining Pediatrix Medical position as of Q1 2022 after selling out during the quarter.
  • Cutler Group sold 6,994 Pediatrix Medical shares in Q1 2022, an estimated $190K.
  • Cutler Group first reported a position in Pediatrix Medical in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Pediatrix Medical position peaked at $321K in Q2 2017.
  • 224 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2022.

Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.